Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Filings indexed 1,096 across all filing types
Latest filing 2014-10-08 Interim / Quarterly Rep…
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q1 2015
2014-10-08 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 7, 2014. It announces the issuance of a press release regarding the company's consolidated financial results for the first quarter of fiscal year 2015. The document itself does not contain the financial results but rather furnishes the press release as an exhibit. The text explicitly states that the information is being furnished and shall not be deemed "filed" for certain regulatory purposes, indicating this is an announcement of financial results rather than the results themselves. The document length is 2965 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results (key highlights only).
2014-10-07 English
FORM 4
Director's Dealing
2014-09-29 English
FORM 4A
Director's Dealing
2014-09-29 English
FORM 4, GREG SKINNER, 9/24/2014
Director's Dealing
2014-09-25 English
FORM 4
Director's Dealing
2014-09-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.